BioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry.
BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites.
BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network.
by David E. Williams Health Business Blog Text messaging isn't exactly big news. Most people have heard about it, even if they associate it only with teens who've given up talking on the phone or even meeting in person in order to spend their time texting. But text messaging has actually ... Read more
by Doug Cress Med Tech Sentinel Natus Medical ( BABY ) announced yesterday that it will acquire SonaMed , a privately held company based in Waltham, MA. SonaMed manufactures and markets the Clarity Screener for the screening of hearing loss in newborns. The company reported rev ... Read more
I was dreading this announcement, but its time has come. My career as a dentist is finally taking off and keeping me too busy to maintain this blog's full potential. Therefore, after a year and a half of surprising success I have no choice but to place BioHealth Investor(BHI) up for sale. BHI is ... Read more
by Michael Shulman BiotechBlitz Antigenics ( AGEN ) got a Russian approval for its cancer immunotherapy -- a cancer "vaccine" is the sexy, headline grabbing term. This also created a few seconds of buzz around two other immunotherapy companies, Dendreon ( DNDN ) and Cell Genesys ... Read more
by Richard Daverman, PhD ChinaBio Today Aida Pharmaceuticals, Inc. (OTCBB: AIDA ) is working on a new wide-spectrum antibiotic that was discovered by its recently acquired affiliate, the Jiangsu Institute of Microbiology Co., Ltd (JSIM). Wetimicin, which belongs to a new generation ... Read more
by David E. Williams Health Business Blog The Associated Press reports that most US states have implemented "drug recycling" programs or are considering doing so. The basic idea is to accept donations of unused drugs and re-dispense them to people in need. It sounds like a good idea on t ... Read more
by Doug Cress Med Tech Sentinel Nanogen and Thermo Fisher Scientific Partner to Provide Molecular Biology Products to the Research Market As the biomedical industry works to gain a better understanding of the molecular basis of disease, the need for specific methods to detect geneti ... Read more
by David E. Williams Health Business Blog The housing market's in a tailspin, gas and food prices are crazy and the "R" word is in the air. Retailers are seeing a drop in business and more people are taking public transportation. But you wouldn't know about any sort of slowdown if you di ... Read more
by Michael Shulman BiotechBlitz Are biotech's turning around? They are certainly beating the market and, frankly, worrying about FDA decisions is easier now than worrying about how much toxic waste is hidden on a bank's balance sheet. I have a good feel for the odds of whether Cell Gen ... Read more
by Richard Daverman, PhD ChinaBio Today China biopharma stocks listed on US exchanges weathered a difficult first quarter of 2008. The ChinaBio ... Read more
Hisham S. Ayoub, DMDFounderBioHealth Investor.comDr.Ayoub recieved his B.Sc. in Human Biology from the University of Toronto, and his Doctorate of Medical Dentistry from Nova Southeastern University in Fort Lauderdale. Dr.Ayoub had always been a keen observer of future trends, especially in science and medicine. This ability, coupled with his passion for journalism and writing, provided all the motivation necessary to establish the BioHealth Investor.Dr.Ayoub hopes that readers and investors find BHI full of interesting and informative articles and commentary.